Frontage Holdings Corp Sustainability Reports
Frontage Holdings Corporation operates as a contract research organization (CRO) that provides integrated drug discovery and development services. The company specializes in bioanalysis, safety and toxicology, preclinical and clinical studies, and product development services for biopharmaceutical companies.
Sector: Professional & technical services
Country: United States
Exchange: Hong Kong Stock Exchange
FIGI: BBG00P4YQTD9
11 reports from 2019 to 2025
- Frontage Holdings Corp 2025 Environmental, Social and Governance (ESG) Report
- Frontage Holdings Corp 2024 Annual Report
- Frontage Holdings Corp 2024 Environmental, Social and Governance (ESG) Report
- Frontage Holdings Corp 2023 Annual Report
- Frontage Holdings Corp 2023 Environmental, Social and Governance (ESG) Report
